nach oben

Erschienen in:

01.02.2015 | Original Article

Does metabolic syndrome worsen systolic dysfunction in diabetes? The shortwave study

verfasst von: Giorgio Faganello, Giovanni Cioffi, Pompilio Faggiano, Riccardo Candido, Luigi Tarantini, Stefania De Feo, Andrea Di Lenarda, Giovanni de Simone

Erschienen in: Acta Diabetologica | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Patients with metabolic syndrome (MetS) have high cardiovascular event rates. The additional effect of MetS on left ventricular (LV) systolic function in patients with type 2 diabetes mellitus (T2DM) is unknown. We studied the relation between MetS and LV systolic function in T2DM patients without coronary artery disease (CAD). Clinical and echocardiographic data from 331 T2DM patients were analyzed. Prevalence of MetS was assessed based on NCEP ATPIII definition. Stress-corrected midwall shortening (sc-MS) and mitral annular peak systolic velocity (S’) were analyzed as indexes of circumferential and longitudinal shortening, respectively. Sc-MS was impaired if <89 %, S’ if <8.5 cm/s (10th percentile of healthy controls). MetS was diagnosed in 172 patients. Sc-MS and S’ were similar in T2DM patients with and without MetS (91 ± 14 vs 92 ± 15 %; 9.8 ± 2.0 vs 9.5 ± 2.1 cm/s, respectively; p = ns) but significantly reduced comparing to controls (102 ± 11 % and 10.8 cm/s; p < 0.0001). Impairment of sc-MS and S’ were detected in 37 vs 40 % and in 29 vs 32 % of T2DM patients with and without MetS (p = ns), respectively. LV systolic function measured as sc-MS and S’ is frequently impaired in T2DM patients without CAD; however, the coexistence of MetS is not associated with more severe LV systolic dysfunction. Further pathological mechanisms have to be considered to explain the negative prognostic impact of MetS in T2DM patients.

Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman PJ, Donato KA et al (2009) Harmonizing the metabolic syndrome: a Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention: National Heart, Lung and Blood institute; American Heart Association; World Heart Federation, International Atherosclerosis Society and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef

Grundy SM, Brewer B, Cleeman JI, Smith SC Jr, Lenfant C et al (2004) Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 109:433–438PubMedCrossRef

Third Report of the National Cholesterol Education Program (NCEP) (2002) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106:3143–3421

Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS et al (2002) Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 28:364–376PubMed

Alexander CM, Landsman PB, Teutsch SM, Haffner SM (2003) NCEP-Defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52:1210–1214PubMedCrossRef

Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716PubMedCrossRef

Ford ES, Giles WH, Mokdad AH (2004) Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27(10):2444–2449PubMedCrossRef

de Simone G, Devereux RB, Chinali M, Best LG, Lee ET, Galloway JM, Resnick HE et al (2007) Impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the strong heart study. Diabetes Care 30(7):1851–1856PubMedCrossRef

Howard BV, Best LG, Galloway JM, Howad WJ, Jones K, Lee ET et al (2006) Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 29(2):391–397PubMedCrossRef

10.

Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR et al (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110:1245–1250PubMedCrossRef

11.

Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C et al (2004) Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 43:1817–1822PubMedCrossRef

12.

Grassi G, Quarti-Trevano F, Seravalle G, Dell’Oro R (2007) Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Nutr Metab Cardiovasc Dis 17:473–481PubMedCrossRef

13.

Mule G, Cottone S, Mongiovi R, Cusimano P, Mezzatesta G, Seddio G et al (2006) Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients. Nutr Metab Cardiovasc Dis 16:54–59PubMedCrossRef

14.

Tartan Z, Ozer N, Uyarel H, Akgul O, Gul M, Cetin M et al (2008) Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction. Nutr Metab Cardiovasc Dis 18(6):441–447PubMedCrossRef

15.

de Simone G, Devereux RB, Chinali M, Roman MJ, Lee ET, Resnick HE et al (2009) Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the strong heart study. Nutr Metab Cardiovasc Dis 19(2):98–104PubMedCentralPubMedCrossRef

16.

Cioffi G, Giorda CB, Chinali M, Di Lenarda A, Faggiano P, Lucci D et al (2012) Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study. Eur J Prev Cardiol 19(5):935–943PubMedCrossRef

17.

de Simone G, Devereux RB, Roman MJ, Chinali M, Barac A, Panza JA et al (2013) Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The strong heart study. Nutr Metab Cardiovasc Dis 23(4):285–291PubMedCentralPubMedCrossRef

18.

Cioffi G, Faganello G, De Feo S, Berlinghieri N, Tarantini L, Di Lenarda A et al (2013) Combined circumferential and longitudinal left ventricular systolic dysfunction in patients with type 2 diabetes mellitus without myocardial ischemia: data from the SHORTWAVE study. Exp Clin Cardiol 18:26–31

19.

Hiestand DM, Britz P, Goldman M, Phillips B et al (2006) Prevalence of symptoms and risk of sleep apnea in the US population: results from the national sleep foundation sleep in America 2005 poll. Chest 130:780–786PubMedCrossRef

20.

Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 19:1378–1384CrossRef

21.

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130(6):461–470PubMedCrossRef

22.

Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458PubMedCrossRef

23.

de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH et al (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056–1062PubMedCrossRef

24.

de Simone G, Daniels SR, Kimball TR, Roman MJ, Chinali M, Galderisi M et al (2005) Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic underestimation. Hypertension 45:64–68PubMedCrossRef

25.

de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH et al (1994) Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 23:1444–1451PubMedCrossRef

26.

Sohn DW, Chai HI, Lee DJ, Kim HC, Oh BH, Lee MM et al (1997) Assessment of mitral annulus velocity by tissue Doppler imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 30:474–480PubMedCrossRef

27.

Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 10:165–193CrossRef

28.

Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194–202PubMedCrossRef

29.

Tadic M, Ivanovic B, Kostic N, Simic D, Matic D, Celic V (2012) Metabolic syndrome and left ventricular function: is the number of criteria actually important? Med Sci Monit 18:282–289CrossRef

30.

Yamaguchi T, Kitamori K, Ichihara G, Suzuki Y, Ochiai M, Yamada Y et al (2013) Serial changes in adipocytokines and cardiac function in a rat model of the metabolic syndrome. Clin Exp Pharmacol Physiol 40:443–448PubMedCrossRef

31.

Galderisi M, de Simone G, Innelli P, Turco A, Turco S, Capalbo B et al (2007) Impaired inotropic response in type 2 diabetes mellitus: a strain rate imaging study. Am J Hypertens 20:548–555PubMedCrossRef

32.

Ha JW, Lee HC, Kang ES, Ahn CM, Kim JM, Ahn JM et al (2007) Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography. Heart 93:1571–1576PubMedCentralPubMedCrossRef

33.

Devereux RB, Roman MJ, Paranicas M, O’Grady MJ, Lee ET, Welty TK et al (2000) Impacts of diabetes on cardiac function. The strong heart study. Circulation 101:2271–2276PubMedCrossRef

34.

Faden G, Faganello G, De Feo S, Berlinghieri N, Tarantini L, Di Lenarda A et al (2013) The increasing detection of asymptomatic left ventricular dysfunction in patients with type 2 diabetes mellitus without overt cardiac disease: data from the SHORTWAVE study. Diabetes Res Clin Pract 101(3):309–316PubMedCrossRef

35.

Tadic M, Ivanovic B, Celic V, Neskovic A (2013) Do nondipping pattern and metabolic syndrome impact left ventricular geometry and global function in hypertensive patients? Clin Exp Hypertens 35(8):637–644PubMedCrossRef

36.

Iozzo P, Lautamaki R, Borra R, Lehto HR, Bucci M, Viljanen A et al (2009) Contribution of glucose tolerance and sex to cardiac adiposity. J Clin Endocrinol Metab 94:4472–4482PubMedCrossRef

37.

Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ et al (2008) Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 52:1793–1799PubMedCrossRef

38.

Willemsen S, Hartog JW, Hummel YM, van Ruijven MH, van der Host IC et al (2011) Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients. Eur J Heart Fail 13:76–82PubMedCrossRef

39.

Koyama Y, Takeishi Y, Arimoto T, Niizeki T, Shishido T et al (2007) High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure. J Card Fail 13:199–206PubMedCrossRef

40.

Fournier SB, Reger BL, Donley DA, Bonner DE, Warden BE, Gharib W et al (2014) Exercise reveals impairments in left ventricular systolic function in patients with metabolic syndrome. Exp Physiol 99(1):149–163PubMedCentralPubMedCrossRef

41.

Crendal E, Walther G, Vinet A, Dutheil F, Naughton G, Lesourd B, Chapier R, Rupp T, Courteix D, Obert P (2013) Myocardial deformation and twist mechanics in adults with metabolic syndrome: impact of cumulative metabolic burden. Obesity 21(12):E679–E686PubMedCrossRef

42.

Partinen M, Jamieson A, Guilleminault C (1988) Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 94:1200–1204PubMedCrossRef

43.

Cioffi G, Russo TE, Selmi A, Stefenelli C, Furlanello F (2011) Analysis of left ventricular systolic function by midwall mechanics in patients with obstructive sleep apnoea. Eur J Echocardiogr 12:61–68PubMedCrossRef

44.

Shamsuzzaman AS, Gersh BJ, Somers VK (2003) Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290(14):1906–1914PubMedCrossRef

45.

Ha TH, Seo HS, Choo WJ, Choi J, Suh J, Cho YH et al (2011) The Effect of Metabolic Syndrome on Myocardial Contractile Reserve during Exercise in Non-Diabetic Hypertensive Subjects. J Cardiovasc Ultrasound 19:176–182PubMedCentralPubMedCrossRef

Titel: Does metabolic syndrome worsen systolic dysfunction in diabetes? The shortwave study
verfasst von: Giorgio Faganello
Giovanni Cioffi
Pompilio Faggiano
Riccardo Candido
Luigi Tarantini
Stefania De Feo
Andrea Di Lenarda
Giovanni de Simone
Publikationsdatum: 01.02.2015
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 1/2015
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-014-0620-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Does metabolic syndrome worsen systolic dysfunction in diabetes? The shortwave study

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2015

Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study

Thanks to Reviewers 2014

Traffic noise and risk of mortality from diabetes

Erratum to: Enhanced insulin sensitivity and acute regulation of metabolic genes and signaling pathways after a single electrical or manual acupuncture session in female insulin-resistant rats

Temporal sequence of the bidirectional relationship between hyperglycemia and periodontal disease: a community-based study of 5,885 Taiwanese aged 35–44 years (KCIS No. 32)

The consequences of failure to achieve targets of guidelines for prevention and treatment of diabetic complications in patients with type 1 diabetes

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin